166 related articles for article (PubMed ID: 34641721)
1. Comparison of Long-Term Outcomes Between 7 Days and 28 Days Albendazole Monotherapy in the Treatment of Single-Lesion Neurocysticercosis in Children.
Johnson N; Saini AG; Malhi P; Khandelwal N; Singhi P
J Child Neurol; 2022 Jan; 37(1):28-34. PubMed ID: 34641721
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
Singh K; Saini AG; Khandelwal N; Singhi P
J Child Neurol; 2022 Apr; 37(5):366-372. PubMed ID: 35213246
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial.
Kalra V; Dua T; Kumar V
J Pediatr; 2003 Jul; 143(1):111-4. PubMed ID: 12915835
[TBL] [Abstract][Full Text] [Related]
4. Fourteen Days vs 28 Days of Albendazole Therapy for Neurocysticercosis in Children: An Open Label Randomized Controlled Trial.
Singla A; Lekhwani S; Vaswani ND; Kaushik JS; Dabla S
Indian Pediatr; 2022 Dec; 59(12):916-919. PubMed ID: 36333896
[TBL] [Abstract][Full Text] [Related]
5. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
Thussu A; Chattopadhyay A; Sawhney IM; Khandelwal N
J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):272-5. PubMed ID: 17928325
[TBL] [Abstract][Full Text] [Related]
6. Long-term Clinical and Radiologic Outcome in 500 Children With Parenchymal Neurocysticercosis.
Singhi P; Suthar R; Deo B; Malhi P; Khandelwal NK
Pediatr Infect Dis J; 2017 Jun; 36(6):549-555. PubMed ID: 28060040
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy.
Singhi P; Ray M; Singhi S; Khandelwal N
J Child Neurol; 2000 Apr; 15(4):207-13. PubMed ID: 10805184
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
Kaur S; Singhi P; Singhi S; Khandelwal N
Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis.
Singhi P; Jain V; Khandelwal N
J Child Neurol; 2004 May; 19(5):323-7. PubMed ID: 15224704
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
Del Brutto OH; Roos KL; Coffey CS; García HH
Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
[TBL] [Abstract][Full Text] [Related]
11. Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis.
Gulati S; Jain P; Sachan D; Chakrabarty B; Kumar A; Pandey RM; Gupta AK
Epilepsy Res; 2014 Sep; 108(7):1212-20. PubMed ID: 24908563
[TBL] [Abstract][Full Text] [Related]
12. The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
Romo ML; Wyka K; Carpio A; Leslie D; Andrews H; Bagiella E; Hauser WA; Kelvin EA;
Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):738-46. PubMed ID: 26433183
[TBL] [Abstract][Full Text] [Related]
13. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial.
Singhi P; Dayal D; Khandelwal N
Pediatr Infect Dis J; 2003 Mar; 22(3):268-72. PubMed ID: 12634590
[TBL] [Abstract][Full Text] [Related]
14. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases.
Gogia S; Talukdar B; Choudhury V; Arora BS
Trans R Soc Trop Med Hyg; 2003; 97(4):416-21. PubMed ID: 15259471
[TBL] [Abstract][Full Text] [Related]
15. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial.
Baranwal AK; Singhi PD; Khandelwal N; Singhi SC
Pediatr Infect Dis J; 1998 Aug; 17(8):696-700. PubMed ID: 9726343
[TBL] [Abstract][Full Text] [Related]
16. Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis.
Carpio A; Chang M; Zhang H; Romo ML; Jaramillo A; Hauser WA; Kelvin EA
Epilepsia; 2019 Sep; 60(9):1820-1828. PubMed ID: 31355931
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
[TBL] [Abstract][Full Text] [Related]
18. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study.
Das K; Mondal GP; Banerjee M; Mukherjee BB; Singh OP
J Clin Neurosci; 2007 Dec; 14(12):1172-7. PubMed ID: 17964789
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of lesion load and efficacy of 3 cycles of albendazole in disseminated cysticercosis: a prospective evaluation.
Pandey S; Malhotra HS; Garg RK; Malhotra KP; Kumar N; Rizvi I; Jain A; Kohli N; Verma R; Sharma P; Uniyal R; Pandey S
BMC Infect Dis; 2020 Mar; 20(1):220. PubMed ID: 32171260
[TBL] [Abstract][Full Text] [Related]
20. Impact of Albendazole Therapy on Clinical and Radiological Outcomes at One Month in Patients with Active Solitary Neurocysticercosis Patients.
Bhattarai S; Thapa L; Maharjan AM; Shrestha AM; Shrestha S; Ghimire MR; Upadhyaya S; Thapa M
Kathmandu Univ Med J (KUMJ); 2022; 20(77):61-65. PubMed ID: 36273293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
